Our research centers on deciphering the molecular mechanisms controlling antitumor immunity, and exploiting knowledge to device new gene- and cell-based cancer immunotherapies.
We have two active research directions:
Our Cell Stem Cell paper reporting HSC-engineering iNKT cell cancer therapy is featured on UCLA News. [PDF][Link]
Dr. Lili Yang receives the Outstanding New Investigator Award from the American Society of Gene & Cell Therapy (ASGCT). [PDF][Link]